Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Anxiety Disorders 6Pain 4Neoplasms 4Sleep Initiation and Maintenance Disorders 3Prostatic Neoplasms 2Nausea 2Hematopoietic and Lymphatic System Neoplasm 2Breast Neoplasms 2Vomiting 1Skin Neoplasms 1Sarcoma 1Respiratory Aspiration 1Neuroblastoma 1Melanoma 1Lymphoma 1Leukemia 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Fatigue 1Dyspnea 1Depression 1Colorectal Neoplasms 1Colonic Polyps 1Chemotherapy Effect 1Carcinoma, Neuroendocrine 1Brain Neoplasms 1Anorexia 1

Interventions

pembrolizumab 23Nivolumab 22aldesleukin 21Cyclophosphamide 20Ipilimumab 17Interleukin-2 17fludarabine 15fludarabine phosphate 14cemiplimab 12Radiotherapy 7Fluorouracil 7Dacarbazine 6binimetinib 5Vemurafenib 5Temozolomide 5Surgical Procedures, Operative 5Sirolimus 5Radiation 5Biopsy 5Aminolevulinic Acid 5encorafenib 4dabrafenib 4Photochemotherapy 4Educational Status 4trametinib 3sonidegib 3montanide ISA 51 3avelumab 3Tacrolimus 3Sodium Chloride 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Skin Neoplasms × Aromatherapy × Clear all
NCT03858855 2020-08-04

Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment

Ohio State University Comprehensive Cancer Center

Phase NA Completed
248 enrolled
DermatologicEndocrineGastrointestinal

Gastrointestinal Neoplasms, Melanoma, Skin Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡